Prosthetic Considerations for Orthodontic Implant Site Development in the Adult Patient
Proper site development is a key factor for long-term clinical success of dental implants. Whereas surgical and restorative techniques have been refined to ensure predictable functional and esthetic outcome, individual clinical prerequisites do not always allow proper placement of implants when prosthetic and material properties are considered. Orthodontic tooth movement may be a viable and nonsurgical site development treatment option. With the introduction and advancements of minimal invasive and less visible orthodontic appliances, a growing number of adult patients are willing to obtain orthodontic treatment. The spectrum of modern appliances is broad and ranges from clear aligners to lingual brackets. Skeletal anchorage devices such as orthodontic mini-implants often eliminate unpopular external anchorage devices (ie, headgear) in adult patients, This article discusses the selection of an appropriate pretreatment approach by taking patient-specific criteria into account.
⁎Associate Professor, University Clinic Erlangen, Dental Clinic 3, Department of Prosthodontics, Erlangen, Germany
†Associate Professor, University Clinic Erlangen, Department of Oral and Maxillofacial Surgery, Erlangen, Germany
‡Professor of Restorative Dentistry, Chairman, Department of Preventive and Restorative Sciences, Robert Schattner Center, University of Pennsylvania, School of Dental Medicine, Philadelphia, PA
§Dental X Hans Geiselhöringer GmbH & Co, Munich, Germany
‖Associate Professor, University Clinic Erlangen, Dental Clinic 2, Department of Prosthodontics, Erlangen, Germany
Address correspondence and reprint requests to Dr Holst: Glueckstrasse, 91054 Erlangen, Germany
Drs Alexandra I. Holst and Emeka Nkenke state no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this article. Dr Stefan Holst has received honoraria from Nobel Biocare. Dr Markus B. Blatz has received research contracts and/or grants from Nobel Biocare, Ekton/Straumann, Heraeus Kulzer, 3M ESPE, Noritake, Kuraray, Coltene Whaledent, and Ivoclar Vivadent. Dr Hans Geiselhöringer has received governance and paid consultantship from Nobel Biocare.
ABSTRACT